StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen trade receivables, net ($M) ($M)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, FY2025
9,570
Period ended Dec 31, 2025
Change on a year earlier
+41.1%
6,782 in FY2024
History
18 years
Since FY2008
Sources
18
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTrade receivables, net ($M) ($M)Year on yearSource
FY2025Dec 31, 20259,570+41.1%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 20246,782-6.7%Form 10-K (filed 2025-02-14) ↗
FY2023Dec 31, 20237,268+30.6%Form 10-K (filed 2024-02-14) ↗
FY2022Dec 31, 20225,563+13.6%Form 10-K (filed 2023-02-09) ↗
FY2021Dec 31, 20214,895+8.2%Form 10-K (filed 2022-02-16) ↗
FY2020Dec 31, 20204,525+11.5%Form 10-K (filed 2021-02-09) ↗
FY2019Dec 31, 20194,057+13.3%Form 10-K (filed 2020-02-12) ↗
FY2018Dec 31, 20183,580+10.6%Form 10-K (filed 2019-02-13) ↗
FY2017Dec 31, 20173,237+2.3%Form 10-K (filed 2018-02-13) ↗
FY2016Dec 31, 20163,165+5.7%Form 10-K (filed 2017-02-14) ↗
FY2015Dec 31, 20152,995+17.6%Form 10-K (filed 2016-02-16) ↗
FY2014Dec 31, 20142,546-5.6%Form 10-K (filed 2015-02-19) ↗
FY2013Dec 31, 20132,697+7.1%Form 10-K (filed 2014-02-24) ↗
FY2012Dec 31, 20122,518-13.1%Form 10-K (filed 2013-02-27) ↗
FY2011Dec 31, 20112,896+24.0%Form 10-K (filed 2012-02-29) ↗
FY2010Dec 31, 20102,335+10.7%Form 10-K (filed 2011-02-25) ↗

Cite this data

StockData. (2026). Amgen Trade receivables, net ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_ar

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.